Disappointing results from CCSVI treatment trial

13th December 2017

Chronic Cerebrospinal Venous Insufficiency (CCSVI) describes a potential reduction in blood flow in the major veins that drain blood from the brain and spinal cord over a prolonged period.

Discovering how immune cells get into the brain in MS

13th December 2017

Study reveals important mechanism that allows immune cells to attack myelin in MS

MS Australia publishes first report on MS Specialist Nurses in Australia

24th November 2017

A major investigation into the critical role of MS Specialist Nurses in Australia could support MS Australia’s advocacy work to increase funding for MSSNs

Art University redecorates facilities of Brazilian MS Association

22nd November 2017

Students and staff from "Universidade Futura do Pintor" renovated the facilities as part of a partnership between the two organisations

Leading Belgian politician presents 2017 “MS@Work” awards

21st November 2017

Belgium’s Deputy Prime Minister, Kris Peeters, presented eight companies with awards to recognise their commitment to hiring people with MS

2017 McDonald Fellowship and Du Pré grant recipients announced

20th November 2017

MSIF is proud to announce the recipients of the 2017 McDonald fellowships and Du Pre grants

Portuguese MS Society (SPEM) launches new Support Line service

20th November 2017

New Support Line will provide information and support, as well as jobs for people living with MS

European Medicines Agency recommends market authorisation for ocrelizumab (Ocrevus) in EU

16th November 2017

The EMA has recommended that ocrelizumab (Ocrevus), the first disease-modifying treatment for primary progressive MS (PPMS), be prescribed for adults with early primary progressive MS

Using Data to individualise patient treatments

6th November 2017

Scientists have been using a large database to develop algorithms to predict individual responses to a particular therapy before starting it.

A new potential biomarker for the diagnosis of MS

6th November 2017

A new small study has discovered molecules in the blood that are specific to people with MS, and can distinguish between relapsing remitting and progressive MS.

Electric stimulation may help manage MS related fatigue

6th November 2017

Researchers have been trialling low current electric brain stimulation as a way to help manage MS related fatigue.

Anti-histamine trial shows myelin repair possible

6th November 2017

Anti-histamine drug clemastine may boost myelin repair in MS